Skip to main content

Editor Spotlight

Each month, Journal of Translational Medicine features an 'Editor spotlight' on a selected Associate Editor in recognition of the commitment, scientific rigor, and integrity that they bring to the journal.  

The archive of the 'Editor spotlight' series can be found below.

October 2022: Sarah Warren

Section: Immunobiology and Immunotherapy

Sarah Warren, PhD is the Senior Director of Research Technologies and Business Development Planning at Kite Pharma. She focuses on advancing cell therapies through integration of novel approaches to CAR-T design and development into Kite's pipeline. Prior to joining Kite, she led Translational Science at NanoString where she focused on collaborating with investigators to use novel spatial and bulk profiling technologies to address unanswered questions in immune oncology. She is a director-at-large for SITC and is an Associate Editor for the Journal of Translational Medicine. She holds a PhD in Immunology from the University of Washington where she studies host-pathogen interactions.

Annual Journal Metrics